Drug-eluting stents: meta-analysis in diabetic patients.
about
Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registryChoosing a revascularization strategy in patients with diabetes and stable coronary artery disease: a complex decisionIs there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?Percutaneous coronary interventions with drug eluting stents for diabetic patientsEfficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History).Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.Efficacy and safety of drug-eluting stents: current best available evidence.Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients.Vascular smooth muscle cell proliferation in restenosis.Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation.Neoatherosclerosis development following bioresorbable vascular scaffold implantation in diabetic and non-diabetic swine.
P2860
Q30687588-9B6B4285-038C-47FB-A0DC-EC6C512EF8EEQ34876677-C4FA8A60-2DC1-40E0-AF93-809D6B8BE85BQ35691400-0E32866D-90B1-4EE5-9BE4-F5B4EBC0805DQ35771445-3FF4C416-C478-4AA0-96D9-CE68D9C4BCEBQ35771807-BF3BB7C0-73B3-4103-9BFF-1D97AB96CB1EQ35888976-AE8F7EA0-A8FF-42F4-AE8B-8DD97F8DC1F7Q36154232-97F4729D-E64A-4F50-95E2-F8B56F01972BQ36488244-A1B45EBF-E2E1-4412-B259-95AE2ED008A0Q36639071-BBA2556D-47EE-4D30-AD33-BC76B90DFBFCQ36977876-D7C4D046-CB61-49B8-BC74-F14DFE8AEEDCQ37388152-6AE8AD95-E128-40D5-B060-14529D1497EAQ37843083-D10A49B2-A0D0-44F7-BC27-66ABCEA32670Q38068350-C35B3287-1792-4582-AA61-07C090D08339Q40964576-8AE49133-1011-4A70-947F-0EB6D476936CQ41230267-DD453ED7-A9B7-4F73-82B8-0182B5336462
P2860
Drug-eluting stents: meta-analysis in diabetic patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Drug-eluting stents: meta-analysis in diabetic patients.
@en
Drug-eluting stents: meta-analysis in diabetic patients.
@nl
type
label
Drug-eluting stents: meta-analysis in diabetic patients.
@en
Drug-eluting stents: meta-analysis in diabetic patients.
@nl
prefLabel
Drug-eluting stents: meta-analysis in diabetic patients.
@en
Drug-eluting stents: meta-analysis in diabetic patients.
@nl
P2093
P1476
Drug-eluting stents: meta-analysis in diabetic patients.
@en
P2093
André J Scheen
Fabian Warzée
Victor M G Legrand
P304
2167-8; author reply 2168-9
P356
10.1016/J.EHJ.2004.07.041
P577
2004-12-01T00:00:00Z